|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
13
|
|
pubmed:dateCreated |
1994-3-31
|
|
pubmed:abstractText |
Acyclovir given for 7 to 10 days is of proved benefit in acute herpes zoster, but studies of its effectiveness in preventing postherpetic neuralgia have had conflicting results. The role of corticosteroids in the treatment of herpes zoster is also controversial.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
0028-4793
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
31
|
|
pubmed:volume |
330
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
896-900
|
|
pubmed:dateRevised |
2010-3-24
|
|
pubmed:meshHeading |
pubmed-meshheading:8114860-Acute Disease,
pubmed-meshheading:8114860-Acyclovir,
pubmed-meshheading:8114860-Adolescent,
pubmed-meshheading:8114860-Adult,
pubmed-meshheading:8114860-Double-Blind Method,
pubmed-meshheading:8114860-Drug Administration Schedule,
pubmed-meshheading:8114860-Drug Therapy, Combination,
pubmed-meshheading:8114860-Female,
pubmed-meshheading:8114860-Herpes Zoster,
pubmed-meshheading:8114860-Humans,
pubmed-meshheading:8114860-Male,
pubmed-meshheading:8114860-Middle Aged,
pubmed-meshheading:8114860-Neuralgia,
pubmed-meshheading:8114860-Pain Measurement,
pubmed-meshheading:8114860-Prednisolone,
pubmed-meshheading:8114860-Statistics as Topic
|
|
pubmed:year |
1994
|
|
pubmed:articleTitle |
A randomized trial of acyclovir for 7 days or 21 days with and without prednisolone for treatment of acute herpes zoster.
|
|
pubmed:affiliation |
Department of Infection and Tropical Medicine, Birmingham Heartlands Hospital, United Kingdom.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
